•
IN
INVA
Innoviva, Inc. Common Stock
yahooPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
1.47B
Volume
12.57K
52W High
$22.76
52W Low
$16.52
Open
$0.00
Prev Close
$19.60
Day Range
0.00 - 0.00
About Innoviva, Inc. Common Stock
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
Latest News
Biotech Is Heating Up—These 2 Red-Hot Stocks Stand Out
Investing.com•Jan 8
Innoviva (INVA) Q2 Sales Jump 64%
The Motley Fool•Aug 7
Basilea announces agreement with Innoviva Specialty Therapeutics for the commercialization of antibiotic Zevtera® (ceftobiprole) in the United States
GlobeNewswire Inc.•Dec 16
Analyst Projects Strong Growth for GSK-Innoviva Partnered Respiratory Drugs
Benzinga•Jun 18
10 stocks you can bet on being inflation-proof
MarketWatch•Mar 2
FDA approves Innoviva’s bacterial pneumonia treatment
MarketWatch•May 24
Over $125M Bet On Occidental Petroleum? Check Out These 4 Stocks Insiders Are Buying
Benzinga•May 16
J&J (JNJ) Q1 Earnings & Sales Top, 2023 View Up, Stock Rises
Zacks Investment Research•Apr 18